Dr. Thomas Moore received his BSc from Clemson University in Bioengineering with a focus on biomaterials. He continued at Clemson and received his PhD in Bioengineering under the direction of Prof. Frank Alexis. His dissertation work was focused on developing theranostic nanoparticles for treating cancer. Before joining the MINDED programme, Thomas worked as a postdoctoral researcher at the Adolphe Merkle Institute in Fribourg, Switzerland under Profs. Alke Petri-Fink and Barbara Rothen-Rutishauser where he studied fundamental interactions of nanoparticles with biological systems. His research interests include understanding particle transport across biological barriers, particles in hydrodynamic systems, and colloidal behavior of particles in complex media.
NanoBAT: Cellular Shuttles to Transport Nanomedicines across the Blood-Brain Barrier